# Optimising Pacing for Contractility 2

Study · id `cardio:ct-nct04201015` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04201015](<https://clinicaltrials.gov/study/NCT04201015>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04201015

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT04201015. Randomized; quadruple masking; primary purpose treatment. Start 2020-06-01 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT04201015, source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)
- Started: 2020-06-01 (actual) (ClinicalTrials.gov record NCT04201015, source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT04201015, source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)
- Completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT04201015, source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04201015, source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04201015-2024-09-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimising Pacing for Contractility 2
- Acronym: OPT-cont 2
- Condition: Heart Failure, Systolic
- Condition: Pacemaker
- Intervention (Device): Heart rate optimisation using force frequency data
- Lead sponsor: University of Leeds
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: University of Leeds (`cardio:org-university-of-leeds`)

## Provenance

Content hash: bee3eb894c012474fa9a88796a3cbf0cb2a8e148055316993cdc430cbb23b445
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
